Email a Friend
Print Article
Hormone Replacement Therapy Q&A
Hormone Replacement Therapy (HRT) for Menopause Symptoms
Find answers to 5 common questions about hormone replacement therapy and menopause from WebMD.
1. Should I stop taking hormone replacement therapy (HRT)?
The answer depends on how long you've been taking hormone replacement therapy, and why.
The Women's Health Initiative found that long-term use (five or more years) of hormone replacement therapy combining two hormones, estrogen and progestin, increased women's risk of heart disease, stroke, blood clots, and breast cancer. The hormone replacement therapy lowered women's risk of broken bones and colorectal cancer.
The risk is very slight. To put it in numbers:
If 10,000 women were taking hormone replacement therapy for a year and 10,000 women were not taking HRT, in the HRT group eight more women would develop invasive breast cancer, seven more would develop heart disease, eight more would have a stroke, and eight more would develop blood clots. There would also be six fewer colorectal cancers and five fewer broken hips.
How do these numbers relate to your personal decision? Every woman is unique, and no one should start or stop hormone replacement therapy without consulting with her doctor. That said, here are some facts that may help you and your doctor arrive at a decision.
Menopause: Not all women experience symptoms such as hot flashes, night sweats, or mood swings during menopause. Those who do usually have the symptoms for just a few years. So don't panic if you need hormone replacement therapy to ease menopause symptoms for a year or two. Most experts today say the benefits of hormone replacement therapy outweigh the risk if hormones are taken for a brief period of time. But if you have been on hormone replacement therapy for several years, or if you started HRT before ever experiencing bothersome symptoms, consider talking with your doctor about tapering off the hormones. You may be surprised. The menopause symptoms you dread may not affect you at all.
Heart Disease: Women taking standard hormone replacement therapy (Prempro, Premphase, Femhrt, and Activella) to prevent heart disease should talk with their doctors about gradually discontinuing the medication. The latest research clearly indicates that hormone replacement therapy does not prevent heart disease. So why did we ever begin prescribing hormone replacement therapy to prevent heart disease? The practice began because observational studies found that women taking hormone replacement therapy tended to have lower rates of heart disease, stroke, colon cancer, and osteoporosis. It now appears, at least in terms of cardiovascular disease, that these women may simply have been healthier and more likely to see a doctor.
Osteoporosis: Research shows that hormone replacement therapy does lower a woman's risk of broken bones. If you are taking hormone replacement therapy to prevent osteoporosis, discuss your family history and treatment options carefully with your doctor. Questions to consider include:
WebMD Medical Reference
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
New-Mom Exercises: Back in Shape
Here's what a mom can do to start getting back in shape shortly after leaving the hospital.
Is Your Pillow Dead? How to Know
